MORE: The Unbelievable Reason You're Short On Vitamin D
4. You're depressed and/or anxious.
While low testosterone likely isn't the sole cause of anyone's depression, research shows it could also have a hand in the disease. In a study of women, ages 25 to 46, those with low testosterone were more likely to be depressed. Other research shows that women with prolonged testosterone deficiency are often both more anxious and more depressed than women with normal testosterone levels.
5. You have a weak grip.
gettyimages-185463533-weak-grip- psphotograph/getty images
Osteoporosis, which causes weak bones, is often considered a women's disease because low estrogen is a key factor in lost bone density. But research shows that low levels of testosterone can leach strength from your skeleton as well, according to Harvard Health . Both men and women who have low levels of testosterone are considered "frail" partially because they can no longer hold a firm handshake. For most women, lack of estrogen will be the main reason osteoporosis sets in, especially following menopause, when the hormone drops dramatically. But replacing estrogen may not be enough if testosterone is also out of balance.
Other side effects include increased risk of heart problems in older men with poor mobility, according to a 2009 study at Boston Medical Center. A 2017 study published in JAMA found that treatments increase coronary artery plaque volume. Additionally, the Food and Drug Administration (FDA) requires manufactures to include a notice on the labeling that states taking testosterone treatments can lead to possible increased risk of heart attacks and strokes. The FDA recommends that patients using testosterone should seek medical attention right away if they have these symptoms:
DHT concentrations increased in parallel with testosterone concentrations at AndroGel 1% doses of 50 mg/day and 100 mg/day, but the DHT/T ratio stayed within the normal range, indicating enhanced availability of the major physiologically active androgen. Serum estradiol (E2) concentrations increased significantly within 30 days of starting treatment with AndroGel 1% 50 or 100 mg/day and remained elevated throughout the treatment period but remained within the normal range for eugonadal men. Serum levels of SHBG decreased very slightly (1 to 11%) during AndroGel 1% treatment. In men with hypergonadotropic hypogonadism, serum levels of LH and FSH fell in a dose- and time-dependent manner during treatment with AndroGel 1%.